TE Hansen-Hagge

Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients

S Yokota, TE Hansen-Hagge, WD Ludwig et al. · Blood · 1991 · 204 citations · Full text

Medicine, Hematology, Oncology +15

Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequences

TE Hansen-Hagge, S Yokota, CR Bartram · Blood · 1989 · 190 citations · Full text

Medicine, Hematology, Oncology +15

Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood

M Wada, CR Bartram, H. Nakamura et al. · Blood · 1993 · 180 citations · Full text

Medicine, Hematology, Oncology +16

The detection of residual acute lymphoblastic leukemia cells with immunologic methods and polymerase chain reaction: a comparative study.

Dario Campana, S Yokota, Elaine Coustan‐Smith et al. · PubMed · 1990 · 65 citations

Medicine, Immunology, Oncology +16

In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cells

M Eder, TE Hansen-Hagge, CR Bartram et al. · Blood · 1992 · 49 citations

Life Sciences, Immunology, Oncology +13